Pharma Fine Chemicals Roundup

Johnson Matthey's Profits Rise on Improved Demand Kerri Walsh Johnson Matthey reported net income for its fiscal year ended March 31, 2011 up 11%, to £182.7 million ($299.4 million), on sales up 27%, to £10 billion. Operating income rose 12%, to £281.2 billion. Sales excluding precious metals soared 29%, to £7.7 billion. Fine chemical sales rose by 11% because of increasing demand for its active pharmaceutical ingredients. SAFC Partners with Pfenex to Codevelop Biopharmaceuticals Alex Scott Pfenex (San Diego), an expert in protein...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers